Causal Relationship between Plasma Liposomes and Autoimmune Thyroid Disease: A Mendelian Randomization Study

Area of Science:

• Endocrinology and Metabolism
• Immunology
• Genetics

Background:

• Autoimmune thyroid disease (AITD) encompasses conditions like autoimmune hyperthyroidism, hypothyroidism, and thyroiditis.
• Observational studies suggest a link between thyroid dysfunction and dyslipidemia, but causality remains unclear.
• Understanding the relationship between plasma lipoproteins and AITD is crucial for elucidating disease mechanisms.

Purpose of the Study:

• To evaluate the causal relationship between plasma lipoproteins and autoimmune thyroid disease using Mendelian randomization.
• To identify specific plasma lipoproteins implicated in the pathogenesis of different AITD subtypes.
• To provide novel insights for potential therapeutic targets in AITD management.

Main Methods:

• Utilized two-sample Mendelian randomization (MR) to assess causality between plasma lipoproteins and AITD.
• Analyzed three subtypes of AITD: autoimmune hyperthyroidism, autoimmune hypothyroidism, and autoimmune thyroiditis.
• Employed Inverse Variance Weighted (IVW) as the primary method, with sensitivity analyses (Cochran Q, MR-Egger intercept, leave-one-out) to test for heterogeneity and pleiotropy.

Main Results:

• MR analysis identified significant causal relationships between eight plasma lipoproteins and autoimmune hyperthyroidism.
• Eleven causal links were found between plasma lipoproteins and autoimmune hypothyroidism, notably involving specific cholesterol esters.
• Sixteen plasma lipoproteins were causally associated with autoimmune thyroiditis, with some increasing and others decreasing risk; sensitivity analyses confirmed result reliability.

Conclusions:

• This Mendelian randomization study establishes a causal relationship between plasma lipoproteins and autoimmune thyroid disease.
• The findings offer fresh insights into the potential mechanisms underlying AITD development.
• These results may contribute to the future development of prevention and treatment strategies for AITD.